Patents Issued in September 17, 2013
  • Patent number: 8535892
    Abstract: It is an object of the present invention to provide novel binding molecules for factor VIII and factor VIII-like proteins. Preferred binding molecules of the present invention exhibit not only distinct characteristics for binding of the target factor VIII polypeptides but also specific and desirable characteristics for release (elution) of the target polypeptides. Especially preferred binding molecules according to the invention are short polypeptide sequences, characterized by a stable loop structure.
    Type: Grant
    Filed: September 23, 2011
    Date of Patent: September 17, 2013
    Assignee: Dyax Corp.
    Inventors: Jinan Yu, M. Daniel Potter, Brian D. Kelley, Jeffrey S. Deetz, James E. Booth
  • Patent number: 8535893
    Abstract: The invention provides methods of identifying herbicidal auxins. The invention further provides auxin-herbicide-resistant plants and genes conferring auxin-herbicide resistance. This invention also provides a method of identifying other proteins that bind picolinate auxins from additional plant species. The invention further provides a method to identify the molecular binding site for picolinate auxins. The invention also includes the use of the picolinate herbicidal auxin target site proteins, and methods of discovering new compounds with herbicidal or plant growth regulatory activity. The invention also includes methods for producing plants that are resistant to picolinate herbicidal auxins. Specific examples of novel proteins associated with herbicide binding include AFB5, AFB4, and SGT1b.
    Type: Grant
    Filed: November 23, 2011
    Date of Patent: September 17, 2013
    Assignee: Agrigenetics, Inc.
    Inventors: Terence A. Walsh, Glenn Hicks, Mary Honma, John P. Davies
  • Patent number: 8535894
    Abstract: Provided are labeling reagents and methods for labeling primary antibodies and for detecting a target in a sample using an immuno-labeled complex that comprises a target-binding antibody and one or more labeling reagents. The labeling reagents comprise monovalent antibody fragments or non-antibody monomeric proteins whereby the labeling proteins have affinity for a specific region of the target-binding antibody and are covalently attached to a label. Discrete subsets of labeling reagent and immune-labeled complexes are provided that facilitate the simultaneous detection of multiple targets in a sample-complexes are distinguished by i) a ratio of label to labeling reagent, or ii) a physical property of said label, or iii) a ratio of labeling reagent to said target-binding antibody, or iv) by said target-binding antibody. This is particularly useful for fluorophore labels that can be attached to labeling reagents and subsequently immuno-labeled complexes in ratios for the detection of multiple targets.
    Type: Grant
    Filed: September 11, 2012
    Date of Patent: September 17, 2013
    Assignee: Life Technologies Corporation
    Inventors: Robert Archer, Richard Haugland, Rosaria Haugland, Joseph Beechem, David Hagen
  • Patent number: 8535895
    Abstract: The invention provides methods, compositions, kits, and systems for the sensitive detection of cardiac troponin. Such methods, compositions, kits, and systems are useful in diagnosis, prognosis, and determination of methods of treatment in conditions that involve release of cardiac troponin.
    Type: Grant
    Filed: November 2, 2012
    Date of Patent: September 17, 2013
    Assignees: Singulex, Inc., The Regents of the University of California
    Inventors: Philippe Goix, Robert Puskas, John Todd, Richard Livingston, Douglas Held, Allan H. B. Wu
  • Patent number: 8535896
    Abstract: The invention relates to a method for the diagnostic investigation of biological samples from a person for inflammation of the liver, in particular hepatic fibrosis and/or cirrhosis of the liver, where the sample is investigated for one or more proteins as markers of inflammation of the liver, in particular hepatic fibrosis and/or cirrhosis of the liver, where a concentration of the proteins which is elevated or decreased by comparison with the healthy state indicates the presence of an inflammation of the liver, in particular a hepatic fibrosis and/or cirrhosis of the liver.
    Type: Grant
    Filed: August 10, 2007
    Date of Patent: September 17, 2013
    Inventors: Wolff Schmiegel, Bence Sipos, Christian Mölleken, Günter Klöppel, Helmut E. Meyer, Barbara Sitek, Kai Stühler
  • Patent number: 8535897
    Abstract: The invention relates to methods for identifying agents, which induce oxidative cell death in a tumor cell. The invention further relates to methods for identifying tumor cells, which are sensitive to agents that induce oxidative cell death. The invention also relates to methods for identifying subjects who are suffering from tumors, which are sensitive to agents that induce oxidative cell death.
    Type: Grant
    Filed: June 19, 2007
    Date of Patent: September 17, 2013
    Assignee: The Trustees of Columbia University in the City of New York
    Inventor: Brent R. Stockwell
  • Patent number: 8535898
    Abstract: Substrates for thrombin and assays for determining the level of bioactive thrombin in a sample are disclosed, wherein the substrate has the general formula: A-X—Z-A? wherein one of either A or A? comprises a luminescent chelate and the other one of A or A? comprises a first partner of a binding pair, X forms a tri- or tetra-peptide, and Z comprises a linker.
    Type: Grant
    Filed: July 15, 2009
    Date of Patent: September 17, 2013
    Assignee: Radiometer Medical APS
    Inventors: Qiu-Ping Qin, Harri Takalo, Allan Milton Byrnard, Kirsten Marie Jakobsen
  • Patent number: 8535899
    Abstract: A novel class of hydroxylases is described having the amino acid sequence of SEQ ID NO: 2, 4, 6 and 8, and variants and fragments thereof having HIF hydroxylation activity. The polypeptides of the invention have in particular prolyl hydroxylase activity. An assay method monitors the interaction of the HIF hydroxylase with a substrate. Modulators of HIF hydroxylase are provided for use in the treatment of a condition associated with increased or decreased HIF levels or activity or for the treatment of a condition where it is desirable to modulate HIF levels or activity.
    Type: Grant
    Filed: January 12, 2010
    Date of Patent: September 17, 2013
    Assignee: Isis Innovation Limited
    Inventors: Patrick Henry Maxwell, Christopher William Pugh, Peter John Ratcliffe, Christopher Joseph Schofield
  • Patent number: 8535900
    Abstract: The invention encompasses the use of a lipolytic enzyme obtainable from one of the following genera: Streptomyces, Corynebacterium and Thermobifida in various methods and uses, wherein the lipolytic enzyme hydrolyzes a glycolipid or a phospholipid or transfers an acyl group from a glycolipid or phospholipids to an acyl acceptor. The present invention also relates to a lipolytic enzyme that hydrolyzes at least a galactolipid or transfers an acyl group from a galactolipid to one or more acyl acceptor substrates, wherein the enzyme is obtainable from Corynebacterium species.
    Type: Grant
    Filed: February 1, 2010
    Date of Patent: September 17, 2013
    Assignee: Dupont Nutrition Biosciences APS
    Inventors: Andrei Miasnikov, Jørn Borch Søe, Jørn Dalgaard Mikkelsen, Mira Povelainen, Virve Pitkanen
  • Patent number: 8535901
    Abstract: The present invention relates to the use of a compound of the following formula (I) for detecting a peptidase activity and/or a variation in pH: according to which: Y1 is a peptide, H or an alkyl; W1, W2, W3 and W4 are independently H, Br, Cl, F, I, alkyl, alkoxy, thiomethyl, perfluoroalkyl, nitro, cyano, carboxyl (including the esters or amides thereof) or any combination thereof; n=0, 1 or 2; U and V are N, N+R or CZ4, R being H, alkyl, aralkyl, aryl, alkanoyl or alkylsulfonyl; Z1, Z2, Z3 and Z4 being independently H, Br, Cl, F, I, alkyl, aryl, alkoxy, perfluoroalkyl, nitro, cyano, carboxyl, sulfonyl, including the carboxyl or sulfonyl esters or amides, and salts thereof.
    Type: Grant
    Filed: July 28, 2010
    Date of Patent: September 17, 2013
    Assignee: bioMérieux, S.A.
    Inventors: Arthur James, Sylvain Orenga, John Perry, Vindhya Salwatura, Stephen Stanforth
  • Patent number: 8535902
    Abstract: The present invention relates to the use of a compound of the following formula (I) for detecting a peptidase activity and/or a variation in pH: according to which: Y1 is a peptide, H or an alkyl; W1, W2, W3 and W4 are independently H, Br, Cl, F, I, alkyl, alkoxy, thiomethyl, perfluoroalkyl, nitro, cyano, carboxyl (including the esters or amides thereof) or any combination thereof; n=0, 1 or 2; X is NR, CZ5Z6, S or O, R being H, alkyl, aralkyl, aryl, alkanoyl or alkylsulfonyl, Z5 and Z6 being an alkyl; Y is N or N+R, R being alkyl, aralkyl, aryl, alkanoyl or alkylsulfonyl; Z1, Z2, Z3 and Z4 being independently H, Br, Cl, F, I, alkyl, aryl, alkoxy, perfluoroalkyl, nitro, cyano, carboxyl, sulfonyl, including the carboxyl or sulfonyl esters or amides, and salts thereof.
    Type: Grant
    Filed: July 27, 2010
    Date of Patent: September 17, 2013
    Assignee: bioMërieux, S.A.
    Inventors: Olivier Fabrega, Arthur James, Sylvain Orenga, John Perry, Vindhya Salwatura, Stephen Stanforth
  • Patent number: 8535903
    Abstract: The invention relates to the use of a compound having formula (I) as an enzymatic substrate for the detection of a nitroreductase activity or as an enzymatic substrate for the detection of a nitroreductase activity and indicator of pH, wherein: W1, W2, W3 and W4 are independently H, Br, Cl, F, I, alkyl, alkoxy, thiomethyl, perfluoroalkyl, nitro, cyano, carboxyl (including the esters or amides thereof) or any combination of same; n=0, 1 or 2; U and V are N, N+R, CZ4, R being H, alkyl, aralkyl, aryl, alkanoic or alkylsulphonic, preferably if U is CZ4, V is N or N+R and, if V is CZ4, U is N or N+R; and Z1, Z2, Z3 and Z4 are independently H, Br, Cl, F, I, alkyl, aryl, alkoxy, perfluoroalkyl, nitro, cyano, carboxyl, sulphonyl, including the sulphonyl or carboxyl amides or esters thereof, and the salts of same.
    Type: Grant
    Filed: July 29, 2010
    Date of Patent: September 17, 2013
    Assignee: BioMerieux, S.A.
    Inventors: Arthur James, Sylvain Orenga, John Perry, Vindhya Salwatura, Stephen Stanforth
  • Patent number: 8535904
    Abstract: A method for adjusting calcium ion in epidermis is described. The method involves applying a material for enhancing skin barrier function to the skin of a subject.
    Type: Grant
    Filed: May 21, 2012
    Date of Patent: September 17, 2013
    Assignee: Pola Chemical Industries Inc.
    Inventors: Shohei Kuroda, Takuya Yamamoto, Yuko Saeki, Masumi Kurasawa
  • Patent number: 8535905
    Abstract: A film (14) with a tissue section (10) is placed with the tissue section (10) downward on a microscope slide (18) and the microscope slide (18) positioned in the object plane of an inverse microscope; where an adhesive tape (20) is arranged, with a bonding agent (22) downward, above the film (14) and therefore above the tissue section (10); wherein the next step, tissue (36) to be isolated is excised by a focused laser beam, which also divides the film (14); whereupon removal of the adhesive tape (20) from the microscope, the excised tissue pieces (36) adhere to the adhesive tape (20), and the remnant of the film (14) and of the tissue section (10) remains adhering/to the microscope slide (18).
    Type: Grant
    Filed: July 24, 2002
    Date of Patent: September 17, 2013
    Assignee: Molecular Machines and Industries AG
    Inventor: Norbert Leclerc
  • Patent number: 8535906
    Abstract: The systems and methods described herein are directed toward the use of radiocarbon analysis techniques in the manufacture of biofuel products. Among other things, methods and systems for using measured fossil-fuel-derived carbon content in biofuel products to guide the design and modification of biofuel manufacturing systems are disclosed.
    Type: Grant
    Filed: April 27, 2010
    Date of Patent: September 17, 2013
    Assignee: Woods Hole Oceanographic Institution
    Inventor: Christopher M. Reddy
  • Patent number: 8535907
    Abstract: Protein concentrates and protein isolates, in addition to processes for the production of protein concentrates and protein isolates, are disclosed. In particular, the disclosure relates to the removal of fiber from a toasted oilseed meal using low g-force centrifugation.
    Type: Grant
    Filed: November 10, 2010
    Date of Patent: September 17, 2013
    Assignee: Bioexx Specialty Proteins Ltd.
    Inventor: Qingnong Nelson Tang
  • Patent number: 8535908
    Abstract: Expression vectors for expression of a protein or polypeptide of interest as a fusion product composed of the protein or polypeptide of interest fused at one terminus to a solubility enhancing peptide extension are provided. Sequences encoding the peptide extensions are provided. The invention further comprises antibodies which bind specifically to one or more of the solubility enhancing peptide extensions.
    Type: Grant
    Filed: January 8, 2010
    Date of Patent: September 17, 2013
    Assignee: Brookhaven Science Associates, LLC
    Inventors: Paul I. Freimuth, Yian-Biao Zhang, Jason Howitt
  • Patent number: 8535909
    Abstract: The present invention relates to a novel non-pathogenic Escherichia coli (E. coli) B BL21 strain comprising a deletion of group II capsular gene cluster, and the use thereof for the production of peptides.
    Type: Grant
    Filed: November 10, 2009
    Date of Patent: September 17, 2013
    Assignee: Novo Nordisk A/S
    Inventors: Helle Fabricius Wöldike, Jianhui Deng, Xin Zhao, Yun Liu, Jing Su
  • Patent number: 8535910
    Abstract: The present invention relates to novel halohydrin dehalogenase polypeptides and the polynucleotides that encode them. These polypeptides are useful in the production of 4-substituted-3-butyric acid derivatives and vicinal cyano, hydroxyl substituted carboxylic acid esters. The invention also provides related vectors, host cells and methods.
    Type: Grant
    Filed: January 12, 2012
    Date of Patent: September 17, 2013
    Assignee: Codexis, Inc.
    Inventors: S. Christopher Davis, Richard J. Fox, Vesna Mitchell, Gjalt W. Huisman, Lisa M. Newman
  • Patent number: 8535911
    Abstract: A progeny cell derived from a parent cell, wherein the progeny cell comprises at least one gene encoding MrgA protein or a functional homologue thereof and/or a DNA segment operably linked with the encoding gene, wherein said gene and/or DNA segment is manipulated with respect to the parent cell; the progeny cell comprises two or more copies of a gene encoding MrgA protein or a functional homologue thereof; or the progeny cell is mutated with respect to the parent cell; whereby the progeny cell produces greater amounts of MrgA protein or a functional homologue thereof than the parent cell.
    Type: Grant
    Filed: August 10, 2012
    Date of Patent: September 17, 2013
    Assignee: Novosymes A/S
    Inventors: Allan Kent Nielsen, Michael Dolberg Rasmussen
  • Patent number: 8535912
    Abstract: The present invention is directed to novel chimeric fibroblast growth factor (FGF) polypeptides, novel DNA encoding chimeric FGF polypeptides, and to the recombinant production of chimeric FGF polypeptides, and to methods, compositions and assays utilizing chimeric FGF polypeptides for the therapeutic treatment of metabolic-related disorders and other conditions, and for producing pharmaceutically active compositions including chimeric FGF polypeptides, the compositions having therapeutic and pharmacologic properties including those associated with the treatment of metabolic-related disorders and other conditions.
    Type: Grant
    Filed: October 15, 2010
    Date of Patent: September 17, 2013
    Assignee: Genentech, Inc.
    Inventor: Junichiro Sonoda
  • Patent number: 8535913
    Abstract: The present invention is directed to a method of producing compositions including embryonic proteins. The method includes culturing cells under hypoxic conditions on a biocompatible three-dimensional surface in vitro. The culturing method produces both soluble and non-soluble fractions, which may be used separately or in combination to obtain physiologically acceptable compositions useful in a variety of medical and therapeutic applications.
    Type: Grant
    Filed: December 7, 2009
    Date of Patent: September 17, 2013
    Assignee: Histogen, Inc.
    Inventors: Gail K. Naughton, Frank Ziegler, Mark Baumgartner, Kyle Nickey
  • Patent number: 8535914
    Abstract: The present invention provides a combination of genes useful for information which can be used for the prediction of postoperative recurrence of gastric cancer and the acquisition of the information, a probe detecting these genes and a primer set for PCR, a method for detecting these genes using the primer and the primer set and a method for obtaining the information which can be used for the prediction of recurrence. Information useful for the prediction of postoperative recurrence can be obtained by determining the presence or absence of gastric cancer cells which show a possibility of postoperative recurrence in a sample such as an peritoneal wash collected from a patient by detecting a particular gene specific to gastric cancer cells or a gene product thereof.
    Type: Grant
    Filed: January 20, 2006
    Date of Patent: September 17, 2013
    Assignees: Canon Kabushiki Kaisha, President of National Cancer Center
    Inventors: Tomohiro Suzuki, Nobuko Yamamoto, Hiroki Sasaki, Kazuhiko Mori
  • Patent number: 8535915
    Abstract: Disclosed are a nucleic acid molecule of Corynebacterium glutamicum origin, having an improved promoter activity, which is operably linked to a gene encoding diaminopimelate dehydrogenase, a vector containing the same, a transformant transformed with the vector, and a method for the production of L-lysine using the transformant.
    Type: Grant
    Filed: January 23, 2009
    Date of Patent: September 17, 2013
    Assignee: CJ Cheiljedang Corporation
    Inventors: Chul Ha Kim, Jong Soo Choi, Sang Jo Lim, Hyung Joon Kim, So Yeon Rah, Gey Hang Jeon
  • Patent number: 8535916
    Abstract: The invention provides a genetically modified microorganism that acquires the ability to consume a renewable feedstock (such as cellulose) and produce products. This organism can be used to ferment cellulose, one of the most abundant renewable resources available, and produce products.
    Type: Grant
    Filed: February 13, 2007
    Date of Patent: September 17, 2013
    Assignee: LS9, Inc.
    Inventors: Stephen B. Del Cardayre, Shane Brubaker, Jay D. Keasling
  • Patent number: 8535917
    Abstract: The present invention relates to methods of synthesizing long-chain polyunsaturated fatty acids, especially eicosapentaenoic acid, docosapentaenoic acid and docosahexaenoic acid, in recombinant cells such as yeast or plant cells. Also provided are recombinant cells or plants which produce long-chain polyunsaturated fatty acids. Furthermore, the present invention relates to a group of new enzymes which possess desatorase or elongase activity that can be used in methods of synthesizing long-chain polyunsaturated fatty acids.
    Type: Grant
    Filed: April 16, 2012
    Date of Patent: September 17, 2013
    Assignee: Commonwealth Scientific and Industrial Research Organisation
    Inventors: Surinder Pal Singh, Stanley Suresh Robert, Peter David Nichols, Susan Irene Ellis Blackburn, Xue-Rong Zhou, James Robertson Petrie, Allan Graham Green
  • Patent number: 8535918
    Abstract: A method of synthesizing optically-active (S)-3-hydroxybutyric acid and (S)-3-hydroxybutyrate ester using a mutated microorganism is provided. More particularly, a mutated microorganism for preparing (S)-3-hydroxybutyric acid transformed with a gene encoding ?-ketothiolase, a gene encoding (S)-3-hydroxybutyryl CoA dehydrogenase and a gene encoding acyl CoA hydrolase; a method of preparing (S)-3-hydroxybutyric acid using the mutated microorganism; a mutated microorganism for preparing (S)-3-hydroxybutyrate ester transformed with a gene encoding ?-ketothiolase, a gene encoding (S)-3-hydroxybutyryl CoA dehydrogenase, a gene encoding acyl CoA hydrolase and a gene encoding lipase; and a method of preparing (S)-3-hydroxybutyrate ester using the mutated microorganism are provided.
    Type: Grant
    Filed: June 10, 2008
    Date of Patent: September 17, 2013
    Assignee: LG Chem, Ltd.
    Inventors: Si Jae Park, Sang Hyun Lee
  • Patent number: 8535919
    Abstract: A process converts a gas input stream comprising CO, CO2, and H2 by contact with fermentation liquid into a liquid product that controls the concentration of CO and CO2 in the fermentation vessel. The process charges the feed gas stream and a recycle gas stream to the fermentation vessel and an off-gas stream collects above the fermentation liquid. The off-gas stream flows to a gas injector that uses a recycle liquid as the motive fluid to mix the off-gas with the recycle liquid into a gas-liquid dispersion. Contact of the recycle liquid with the off-gas absorbs CO2 to provide the recycle stream. A gas separation vessel separates the remainder of the off-gas into the recycle gas. Mixing the recycle gas with the gas input stream dilutes the concentration of CO to lower the CO concentration in the fermentation vessel. Separated recycle liquid flows to a CO2 stripper for removal of CO2.
    Type: Grant
    Filed: June 30, 2010
    Date of Patent: September 17, 2013
    Assignee: Coskata, Inc.
    Inventor: Robert Hickey
  • Patent number: 8535920
    Abstract: The present invention relates to a process for producing efficiently glutamic acid derivatives (including salts thereof) such as monatin by converting a substituted ?-keto acid of formula (1) into a glutamic acid derivative of formula (2) in the presence of an enzyme catalyzing conversion of the same.
    Type: Grant
    Filed: November 20, 2006
    Date of Patent: September 17, 2013
    Assignee: Ajinomoto Co., Inc.
    Inventors: Masakazu Sugiyama, Kunihiko Watanabe, Nao Funakoshi, Yusuke Amino, Shigeru Kawahara, Tadashi Takemoto
  • Patent number: 8535921
    Abstract: At least one isolated microorganism and a fermentation method to convert hydrogen gas, carbon dioxide gas, and/or carbon monoxide gas to a lower alkyl alcohol and/or carboxylic acid and to produce at least 2% by volume of the lower alkyl alcohol or carboxylic acid in an aqueous-based medium.
    Type: Grant
    Filed: March 26, 2012
    Date of Patent: September 17, 2013
    Inventors: Richard Allen Kohn, Seon-Woo Kim
  • Patent number: 8535922
    Abstract: The present invention provides a method for producing an ethanol from a lignocellulose resource efficiently. According to the method for producing the ethanol of the present invention, an enzyme group derived from a mushroom waste substrate has a high activity and can allow cellulose or xylan in the lignocellulose resource to be efficiently converted into glucose or xylose. That is, the lignocellulose resource can be converted into a saccharified solution including the glucose or xylose thereinside. The glucose or xylose in the saccharified solution can be converted into the ethanol by fermentation of yeast or bacterium provided into the saccharified solution. The method for producing the ethanol of the present invention can allow the ethanol to be efficiently produced from the lignocellulose resource.
    Type: Grant
    Filed: January 13, 2009
    Date of Patent: September 17, 2013
    Assignee: Hokto Corporation
    Inventors: Tetsuro Nishimoto, Kiyohiro Nishimoto, Tsutomu Morinaga
  • Patent number: 8535923
    Abstract: Microcapsules including a capsule shell encapsulating a suspension of a therapeutically effective amount of liver cells in physical contact with a liver cell stimulating amount of erythropoietin.
    Type: Grant
    Filed: April 27, 2010
    Date of Patent: September 17, 2013
    Assignee: Cytonet GmbH & Co. KG
    Inventors: Krasimira Aleksandrova, Peter Pediaditakis, Jo Salisbury, Wolfgang Rüdinger
  • Patent number: 8535924
    Abstract: A granule with an allergenic component has reduced dust by including antifoam added during the production of the granule. The antifoam may be dispersed throughout the granule or added to one of the components of the granule. The granule with antifoam produces at least 30% less dust than a comparable granule produced according to a process in which no antifoam is added.
    Type: Grant
    Filed: November 3, 2011
    Date of Patent: September 17, 2013
    Assignee: Danisco US Inc.
    Inventors: Douglas A. Dale, Thomas S. Green
  • Patent number: 8535925
    Abstract: Modified DNase polypeptides and methods of their use are provided.
    Type: Grant
    Filed: April 2, 2010
    Date of Patent: September 17, 2013
    Assignee: Bio-Rad Laboratories, Inc.
    Inventors: Gayathri Ramaswamy, Yan Wang
  • Patent number: 8535926
    Abstract: Two novel cellulases and nucleotide sequences encoding the same are disclosed. Also disclosed are compositions and methods for using the same for hydrolyzing cellulosic waste materials.
    Type: Grant
    Filed: March 13, 2011
    Date of Patent: September 17, 2013
    Assignee: Academia Sinica
    Inventors: Yu-Chan Chao, Chia-Jung Chang
  • Patent number: 8535927
    Abstract: The present invention provides novel serine proteases, novel genetic material encoding these enzymes, and proteolytic proteins obtained from Micrococcineae spp., including but not limited to Cellulomonas spp. and variant proteins developed therefrom. In particular, the present invention provides protease compositions obtained from a Cellulomonas spp, DNA encoding the protease, vectors comprising the DNA encoding the protease, host cells transformed with the vector DNA, and an enzyme produced by the host cells. The present invention also provides cleaning compositions (e.g., detergent compositions), animal feed compositions, and textile and leather processing compositions comprising protease(s) obtained from a Micrococcineae spp., including but not limited to Cellulomonas spp. In alternative embodiments, the present invention provides mutant (i.e., variant) proteases derived from the wild-type proteases described herein. These mutant proteases also find use in numerous applications.
    Type: Grant
    Filed: November 19, 2004
    Date of Patent: September 17, 2013
    Assignee: Danisco US Inc.
    Inventors: Brian E. Jones, Marc Kolkman, Chris Leeflang, Hiroshi Oh, Ayrookaran J. Poulose, Eugene S. Sadlowski, Andrew Shaw, Leo van Marrewijk, Wilhelmus A. H. Van Der Kleij
  • Patent number: 8535928
    Abstract: A novel protease comprising any one of (a) the amino acid sequence of SEQ ID NO: 1, (b) an amino acid sequence having deletion, substitution or addition of one to several amino acids in the amino acid sequence of SEQ ID NO: 1, (c) the amino acid sequence of SEQ ID NO: 3, and (d) an amino acid sequence having deletion, substitution or addition of one to several amino acids in the amino acid sequence of SEQ ID NO: 3, has a high activity under high temperature and high alkaline conditions, a high stability to protein denaturants and surfactants and high effectiveness as a protease used in detergents.
    Type: Grant
    Filed: July 30, 2009
    Date of Patent: September 17, 2013
    Assignee: Osaka University
    Inventors: Shigenori Kanaya, Tita Foophow, Kazufumi Takano, Yuichi Koga
  • Patent number: 8535929
    Abstract: A parvovirus characterized by a CpG-enriched genome, wherein the genome contains at least 2 additional CpG inserts that are not present in the wild type genome is described as well as the use of said parvovirus, e.g., a parvovirus based on parvovirus H1, LuIII, Mouse minute virus (MMV), Mouse parvovirus (MPV), Rat minute virus (RMV), Rat parvovirus (RPV), Rat virus (RV), vectors based on the foregoing viral species, and/or cells capable of actively producing the foregoing viral species for the preparation of a pharmaceutical composition, e.g., for the treatment of cancer, preferably pancreas carcinoma, hepatoma or lymphoma.
    Type: Grant
    Filed: December 19, 2008
    Date of Patent: September 17, 2013
    Assignees: Deutsches Krebsforschungszentrum, Ruprecht-Karls-Universitaet Heidelberg
    Inventors: Zahari Raykov, Jean Rommelaere, Nathalia Giese, Marc Aprahamian
  • Patent number: 8535930
    Abstract: The invention relates to a method of producing a HPV polypeptides and/or an influenza virus H5 polypeptide in a plant comprising the steps of cloning a HPV gene; and/or an influenza virus H5 gene or nucleic acid encoding their functional equivalents into a vector adapted to target components present in the plant, infiltrating at least a portion of the plant with the vector or transforming plant tissue with the vector so as to transiently express the HPV polypeptides and/or an influenza virus H5 polypeptide, and/or to create a transgenic plant; and recovering the HPV polypeptides and/or an influenza virus H5 polypeptide expressed by the plant. The invention further relates to vectors, transgenic plants or parts thereof and the progeny of such plants used in or which come about as a result of the method.
    Type: Grant
    Filed: May 2, 2006
    Date of Patent: September 17, 2013
    Assignee: University of Cape Town
    Inventors: Anna-Lise Williamson, Edward Peter Rybicki, James Malcolm MacLean, Inga Isabel Becker-Hitzeroth
  • Patent number: 8535931
    Abstract: The invention relates to the enrichment of non-photosynthetic micro-organisms with organic selenium, and more particularly with selenomethionine, from a compound of the seleno-hydroxyacid type such as 2-hydroxy-4-methylseleno-butanoic acid in the (D, L) form or in the form of an enantiomer, salt, ester, or amide derivative of said compound, and to the use of micro-organisms, particularly bacteria thus enriched in the fields of animal or human nutrition, cosmetics, or pharmaceuticals.
    Type: Grant
    Filed: August 28, 2009
    Date of Patent: September 17, 2013
    Assignee: Tetrahedron
    Inventors: Jean-Claude Yadan, Marc Moutet
  • Patent number: 8535932
    Abstract: A microbial pesticide which is safe for the environment, fast-acting and excellent in an insecticidal effect in case of spray treatment for eggs and larvae of a pest is required. The invention provides a method for controlling at least one pest selected from the group consisting of whiteflies, aphid, spider mites, thrips, rust mites, leaf miners, pyralidae, cabbage moths and longhorn beetles, with Lecanicillium muscarium strain V-5 (deposition number: FERM BP-11135); and a microbial pesticide comprising the strain.
    Type: Grant
    Filed: August 11, 2009
    Date of Patent: September 17, 2013
    Assignee: Ishihara Sangyo Kaisha, Ltd
    Inventors: Satoshi Araki, Munekazu Ogawa, Takayuki Kashima
  • Patent number: 8535933
    Abstract: A method and process is provided to help increase flow within the piping of a clinical vacuum system under low flow inlet conditions and to re-establish flow under zero flow inlet conditions, among other things. The method and process broadly uses the steps of isolating and accessing the piping of the clinical vacuum system, introducing an enzymatic solution to the piping, and then extracting the solution following exposure of the solution to the piping to remove complex organic materials from the piping. A portable collection canister can be used to measure the amount of enzymatic solution that is put into the piping and removed from the piping to ensure that the system is dry. The collection canister can be connected via hose to a zone valve box of the system or to a service valve of the system.
    Type: Grant
    Filed: January 5, 2012
    Date of Patent: September 17, 2013
    Inventor: Scott E. Lisec
  • Patent number: 8535934
    Abstract: The invention, in various embodiments, provides systems, methods and solutions using an organ ex vivo.
    Type: Grant
    Filed: April 19, 2007
    Date of Patent: September 17, 2013
    Assignee: TransMedics, Inc.
    Inventors: Waleed Hassanein, Tamer Khayal, Robert Havener, Stanley Kyi, Ihab Abdel Fattah, Hesham Saleh, Jon Trachtenberg
  • Patent number: 8535935
    Abstract: A cell culture measuring system and to a method for comparative investigations on cell cultures. In a cell culture measuring system, cell cultures are cultivated on a cell culture carrier within a flow passage. An inflow and an outflow for a liquid culture medium and at least two sensors are present. At least one further inflow for a test liquid is arranged in the flow direction of the culture medium between the inflow for the culture medium and the outflow of the flow passage so that the test liquid flowing through the flow passage by displacement of the culture medium only flows around and/or over some of the cells present on the cell culture carrier. At least one sensor is arranged in the region of the cells not influenced by test liquid and at least one sensor is arranged in the region of cells influenced by test liquid.
    Type: Grant
    Filed: August 8, 2008
    Date of Patent: September 17, 2013
    Assignee: Fraunhofer-Gesellschaft zur Foerderung der Angewandten Forschung E.V.
    Inventors: Frank Sonntag, Florian Mehringer, Niels Schilling, Martin Jaeger
  • Patent number: 8535936
    Abstract: A flexible vessel for mixing a bioprocessing fluid has contact points or adhesions between its front and back walls to promote and guide flow patters for mixing the contents.
    Type: Grant
    Filed: April 23, 2009
    Date of Patent: September 17, 2013
    Assignee: TwistaFerm
    Inventors: Henry R. Bungay, III, James S. Bungay, John G. Sigsby
  • Patent number: 8535937
    Abstract: A device and method for detecting by fluorescence microbial growth from sample substances are disclosed. For example, a method for the detection of visible-band fluorescence signals generated by at least one fluorescing compound excited by ultraviolet energy, comprising exciting said at least one fluorescing compound with ultraviolet energy emitted from a light-emitting diode comprising wavelengths below 400 nanometers, and detecting a visible-band fluorescence signal generated by said at least one excited fluorescing compound with at least one light detector sensitive to electromagnetic energy comprising wavelengths greater than or equal to 400 nanometers wavelength.
    Type: Grant
    Filed: May 17, 2011
    Date of Patent: September 17, 2013
    Assignee: Neogen Corporation
    Inventor: Gideon Eden
  • Patent number: 8535938
    Abstract: A system and apparatus for sorting a mixture of stained particles in a fluid flow path, including stained particles. The system can include a pulsed electromagnetic radiation source for exciting fluorescence emissions from the stained particles, a photodetector for detecting the fluorescence emissions from the stained particles, a processor for classifying the stained particles; and a photo-damaging laser for damaging selected particles in the flow path.
    Type: Grant
    Filed: March 16, 2012
    Date of Patent: September 17, 2013
    Assignee: Inguran, LLC
    Inventors: Gary Durack, Jeffrey D. Wallace, Gary P. Vandre, Lon A. Westfall, Jeremy T. Hatcher, Niraj V. Nayak
  • Patent number: 8535939
    Abstract: The present invention relates to a secretory signal, a plasmid containing the secretory signal, a transformed anaerobic bacterium transformed with said plasmid, a gene transfer carrier consisting of said anaerobic bacterium, and a pharmaceutical composition containing said carrier.
    Type: Grant
    Filed: January 28, 2011
    Date of Patent: September 17, 2013
    Assignee: Anaeropharma Science, Inc.
    Inventors: Yuko Shimatani-Shibata, Hitomi Shimizu-Matsuhashi, Takayuki Sasaki
  • Patent number: 8535940
    Abstract: The invention concerns the field of cell culture technology. It concerns a method of improving cell growth, especially the growth of biopharmaceutical producer host cells. The invention further concerns a method of producing proteins using the cells generated by the described method.
    Type: Grant
    Filed: January 22, 2008
    Date of Patent: September 17, 2013
    Assignee: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Hitto Kaufmann, Lore Florin, Eric Becker
  • Patent number: 8535941
    Abstract: Compositions useful for detecting Clostridial toxin activity comprising a cell that comprises a membrane-associated Clostridial toxin substrate comprising a first member of a fluorescence resonance energy transfer pair; and a Clostridial toxin recognition sequence including a cleavage site; and a membrane-associated second member of the FRET pair and methods useful for determining Clostridial toxin activity using such Clostridial toxin substrates.
    Type: Grant
    Filed: February 27, 2012
    Date of Patent: September 17, 2013
    Assignee: Allergan, Inc.
    Inventors: Ester Fernandez-Salas, Lance E. Steward, Kei Roger Aoki